Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1981 Feb;134(2):153–158.

Immunoglobulin D myeloma: report of a case with unusual neurological complications.

V Caggiano, S L Nielsen, F J Glassy, D F Dozier Jr
PMCID: PMC1272548  PMID: 7222664

Full text

PDF
153

Images in this article

154Figure 1.
on p.154
155Figure 2.
on p.155
155Figure 3.
on p.155

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRECHER G., TANAKA Y., MALMGREN R. A., FAHEY J. L. MORPHOLOGY AND PROTEIN SYNTHESIS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA. Ann N Y Acad Sci. 1964 Feb 28;113:642–653. doi: 10.1111/j.1749-6632.1964.tb40696.x. [DOI] [PubMed] [Google Scholar]
  2. Bernier G. M., Graham R. C., Jr Plasma cell asynchrony in myeloma: correlation of light and electron microscopy. Semin Hematol. 1976 Jul;13(3):239–245. [PubMed] [Google Scholar]
  3. Burlando L., Milone S., Acquarone N., Comelli A. Gamma-D-mieloma. Segnalazione di due casi. Pathologica. 1978 Jan-Feb;70(999-1000):39–52. [PubMed] [Google Scholar]
  4. CLARKE E. Cranial and intracranial myelomas. Brain. 1954;77(1):61–81. doi: 10.1093/brain/77.1.61. [DOI] [PubMed] [Google Scholar]
  5. Case D. C., Jr, Lee D. J., 3rd, Clarkson B. D. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. Am J Med. 1977 Dec;63(6):897–903. doi: 10.1016/0002-9343(77)90543-5. [DOI] [PubMed] [Google Scholar]
  6. Cooney T., Sweeney E. The hen's tooth: arterial aneurysm resulting from invasion by IgD myeloma cells. Ir J Med Sci. 1977 Sep;146(9):295–297. doi: 10.1007/BF03030978. [DOI] [PubMed] [Google Scholar]
  7. Durie B. G., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975 Sep;36(3):842–854. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  8. Feest T. G., Burge P. S., Cohen S. L. Successful treatment of myeloma kidney by diuresis and plasmaphoresis. Br Med J. 1976 Feb 28;1(6008):503–504. doi: 10.1136/bmj.1.6008.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fishkin B. G., Glassy F. J., Hattersley P. G., Hirose F. M., Spiegelberg H. L. IgD multiple myeloma: a report of five cases. Am J Clin Pathol. 1970 Feb;53(2):209–214. doi: 10.1093/ajcp/53.2.209. [DOI] [PubMed] [Google Scholar]
  10. Graham R. C., Jr, Bernier G. M. The bone marrow in multiple myeloma: correlation of plasma cell ultrastructure and clinical state. Medicine (Baltimore) 1975 May;54(3):225–243. doi: 10.1097/00005792-197505000-00004. [DOI] [PubMed] [Google Scholar]
  11. Ioachim N. J., McKenna P. J., Halperin I., Chung F. J. IgD myeloma: immunology and ultrastructure. Ann Clin Lab Sci. 1978 May-Jun;8(3):209–218. [PubMed] [Google Scholar]
  12. Isobe T., Ikeda Y., Ohta H., Imura H. IgD myeloma--a clinical study of 9 cases. Nihon Ketsueki Gakkai Zasshi. 1976 Jun;39(3):319–328. [PubMed] [Google Scholar]
  13. Jancelewicz Z., Takatsuki K., Sugai S., Pruzanski W. IgD multiple myeloma. Review of 133 cases. Arch Intern Med. 1975 Jan;135(1):87–93. [PubMed] [Google Scholar]
  14. Jákó J., Virágh S., Brooser G., Dóbiás G., Domán J., Ottó, Riskó Z., Szemere P. A case of IgD-lambda myeloma. Haematologia (Budap) 1975;9(3-4):261–278. [PubMed] [Google Scholar]
  15. Knowles D. M., 2nd, Halper J. A., Trokel S., Jakobiec A. Immunofluorescent and immunoperoxidase characteristics of IgDlambda myeloma involving the orbit. Am J Ophthalmol. 1978 Apr;85(4):485–494. doi: 10.1016/s0002-9394(14)75246-8. [DOI] [PubMed] [Google Scholar]
  16. Koeffler H. P., Cline M. J. Multiple myeloma presenting as ascites. West J Med. 1977 Sep;127(3):248–250. [PMC free article] [PubMed] [Google Scholar]
  17. Kyle R. A., Elveback L. R. Management and prognosis of multiple myeloma. Mayo Clin Proc. 1976 Dec;51(12):751–760. [PubMed] [Google Scholar]
  18. Kyle R. A. Multiple myeloma: review of 869 cases. Mayo Clin Proc. 1975 Jan;50(1):29–40. [PubMed] [Google Scholar]
  19. Lee B. J., Sahakian G., Clarkson B. D., Krakoff I. H. Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU. Cancer. 1974 Feb;33(2):533–538. doi: 10.1002/1097-0142(197402)33:2<533::aid-cncr2820330231>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  20. Leech S. H., Polesky H. F., Shapiro F. L. Chronic hemodialysis in myelomatosis. Ann Intern Med. 1972 Aug;77(2):239–242. doi: 10.7326/0003-4819-77-2-239. [DOI] [PubMed] [Google Scholar]
  21. Maldonado J. E., Brown A. L., Jr, Bayrd E. D., Pease G. L. Cytoplasmic and intranuclear electron-dense bodies in the myeloma cell. Arch Pathol. 1966 Jun;81(6):484–500. [PubMed] [Google Scholar]
  22. McPhedran P., Heath C. W., Jr, Garcia J. Multiple myeloma incidence in metropolitan Atlanta, Georgia: racial and seasonal variations. Blood. 1972 Jun;39(6):866–873. [PubMed] [Google Scholar]
  23. Nobler M. P. Mental nerve palsy in malignant lymphoma. Cancer. 1969 Jul;24(1):122–127. doi: 10.1002/1097-0142(196907)24:1<122::aid-cncr2820240116>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  24. Pruzanski W. Clinical manifestations of multiple myeloma: relation to class and type M component. Can Med Assoc J. 1976 May 22;114(10):896–897. [PMC free article] [PubMed] [Google Scholar]
  25. ROWE D. S., FAHEY J. L. A NEW CLASS OF HUMAN IMMUNOGLOBULINS. I. A UNIQUE MYELOMA PROTEIN. J Exp Med. 1965 Jan 1;121:171–184. doi: 10.1084/jem.121.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. SILVERSTEIN A., DONIGER D. E. NEUROLOGIC COMPLICATIONS OF MYELOMATOSIS. Arch Neurol. 1963 Nov;9:534–544. doi: 10.1001/archneur.1963.00460110102011. [DOI] [PubMed] [Google Scholar]
  27. Schur P. H., Kyle R. A., Bloch K. J., Hammack W. J., Rivers S. L., Sargent A., Ritchie R. F., McIntyre O. R., Moloney W. C., Wolfson L. IgG subclasses: relationship to clinical aspects of multiple myeloma and frequency distribution among M-components. Scand J Haematol. 1974;12(1):60–68. doi: 10.1111/j.1600-0609.1974.tb00181.x. [DOI] [PubMed] [Google Scholar]
  28. Sundaresan N., Noronha A., Hirschauer J., Siqueira E. B. Oculomotor palsy as initial manifestation of myeloma. JAMA. 1977 Nov 7;238(19):2052–2053. [PubMed] [Google Scholar]
  29. Tichý M., Hrncír Z., Pola V., Mazák J. Immunochemical analysis of IgD-lambda paraprotein in myeloma. Neoplasma. 1974;21(4):487–491. [PubMed] [Google Scholar]
  30. Toth J. IgD myeloma: a case report. Can Med Assoc J. 1977 Jun 4;116(11):1235-6, 1238. [PMC free article] [PubMed] [Google Scholar]
  31. Udoji W. C., Pemmaraju S. IgD myeloma with myelofibrosis and amyloidosis. Arch Pathol Lab Med. 1977 Jan;101(1):10–13. [PubMed] [Google Scholar]
  32. Valenzuela R., Govindarajan S., Tubbs R., Deodhar S., Bukowski R. IgD myeloma. Report of a case with unusual clinical and immunologic features. Am J Clin Pathol. 1979 Aug;72(2):246–250. doi: 10.1093/ajcp/72.2.246. [DOI] [PubMed] [Google Scholar]
  33. Vaziri N. D., Goldman R., Schultze R. G., Lee D. B., Rosen S. M. Maintenance hemodialysis in myeloma kidney disease. West J Med. 1977 Feb;126(2):91–94. [PMC free article] [PubMed] [Google Scholar]
  34. Virella G., Hobbs J. R. Heavy chain typing in IgG monoclonal gammopathies with special reference to cases of serum hyperviscosity and cryoglobulinaemia. Clin Exp Immunol. 1971 Jun;8(6):973–980. [PMC free article] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES